Oric Pharmaceuticals, Inc. (ORIC)
Nasdaq: ORIC · Pharmaceutical Preparations · South San Francisco, CA · filing with the SEC since 2019
Who owns Oric Pharmaceuticals, Inc.
As filed with the SECHolders of 5% or more
5
Nextech Crossover I GP S.a. r.l. holds 8.4% of Common Stock, $0.0001 par value per share, as its SCHEDULE 13G/A filed Aug 14, 2025 says.
Directors and officers
8
report now, of 13 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Nextech Crossover I GP S.a. r.l.
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, $0.0001 par value per share
Viking Global Investors LP
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.0001 par value per share · 9.99% in Aug 14, 2025
EcoR1 Capital, LLC
SCHEDULE 13G · filed Aug 5, 2025 · Common Stock
Blackrock, Inc.
SCHEDULE 13G · filed Jan 21, 2026 · Common Stock · 4.2% in Jul 17, 2025
T. Rowe Price Associates, Inc.
SCHEDULE 13G · filed May 15, 2026 · COMMON STOCK
SR One Capital Management, LLC
SCHEDULE 13D/A · filed Aug 14, 2025 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 5.4% in Jun 5, 2025
Alkeon Capital Management LLC
SCHEDULE 13G/A · filed Nov 13, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%
Venrock Healthcare Capital Partners III, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 5.8% in Feb 17, 2026
David V Goeddel
SCHEDULE 13G/A · filed Nov 17, 2025 · Common Stock, $0.0001 par value per share · reported falling below 5%
Fmr LLC
SCHEDULE 13G/A · filed Feb 12, 2025 · COMMON STOCK · reported falling below 5%
Pfizer Inc.
SCHEDULE 13G/A · filed May 12, 2026 · Common Stock par value $0.0001 per share · reported falling below 5%
James N. Topper
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, $0.0001 par value per share · reported falling below 5%
Point72 Asset Management, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 5.1% in Jun 4, 2025
What ORIC reports owning in othersstakes of 5% or more, and other ties
Oric Pharmaceuticals, Inc. reports no stake in another company in the record.
Insider tradesForm 4
16sales
0purchases
13sales on a scheduled plan
4people selling
$3.0Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 21, 2025 to Oct 21, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 21, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 22 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Piscitelli Dominic | Chief Financial Officer | 7 | $2.2M | 6 | 0 | $0 |
| Chacko Jacob | PRESIDENT AND CEO | 1 | $300,000 | 0 | 0 | $0 |
| Heyman Richard A. | director | 7 | $300,000 | 7 | 0 | $0 |
| Multani Pratik S | Chief Medical Officer | 1 | $100,000 | 0 | 0 | $0 |